YHLO

2019-10-23

Summary:The annual event is upcoming! In this early winter, in Dusseldorf, the world of medicine will meet at MEDICA 2019.





The annual event is upcoming! In this early winter, in Dusseldorf, the world of medicine will meet at MEDICA 2019. As an immunoassay solutions provider, YHLO won’t be absent. We hereby sincerely invite you and your company representatives to visit our booth (No.1D25) during 18-21 November 2019. Our team is looking forward to seeing you there!

Are you already curious what you can experience at MEDICA 2019?

In this MEDICA, the recently launched iModule Modular System, which can be expandable to up to 4 units of iFlash 3000, will be showcased, as well as the bench-top iFlash 1800. With up to 112 CLIA parameters including autoimmunity, reproductive health, infectious disease and diabetes, the iFlash series are designed for various medical conditions.

More solutions and test panels will be exhibited. You’re welcome to schedule an appointment with us in advance.

Previous: YHLO at MEDICA 2019

Next: YHLO at AACC 2019: Showing immunoassay and beyond

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +